Oncotarget

Vol 11, No 41

October 13, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 41 of Oncotarget features Figure 7, "IPA ATM-signaling pathway in (A) EFV treated MRC-5 and (B) A549 cells," by Marima, et al.

Table of Contents

Research Papers

Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer

Combination of copanlisib with cetuximab improves tumor response in cetuximab-resistant patient-derived xenografts of head and neck cancer

https://doi.org/10.18632/oncotarget.27763

Konrad Klinghammer, Oliver Politz, Theresa Eder, Raik Otto, Jan-Dirk Raguse, Andreas Albers, Andreas Kaufmann, Ingeborg Tinhofer, Jens Hoffmann, Ulrich Keller,  and Ulrich Keilholz
3688-3697
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties in vivo

A novel format for recombinant antibody-interleukin-2 fusion proteins exhibits superior tumor-targeting properties in vivo

https://doi.org/10.18632/oncotarget.27726

Tiziano Ongaro, Baptiste Gouyou, Marco Stringhini, Riccardo Corbellari, Dario Neri,  and Alessandra Villa
3698-3711
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Evaluation of cancer-derived myocardial impairments using a mouse model

Evaluation of cancer-derived myocardial impairments using a mouse model

https://doi.org/10.18632/oncotarget.27759

Yoshihiro Miyagawa, Shota Nukaga, Takuya Mori, Rina Fujiwara-Tani, Kiyomu Fujii, Shiori Mori, Kei Goto, Shingo Kishi, Takamitsu Sasaki, Chie Nakashima, Hitoshi Ohmori, Isao Kawahara, Yi Luo,  and Hiroki Kuniyasu
3712-3722
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment

Melatonin increases overall survival of prostate cancer patients with poor prognosis after combined hormone radiation treatment

https://doi.org/10.18632/oncotarget.27757

Gennady M. Zharinov, Oleg A. Bogomolov, Irina V. Chepurnaya, Natalia Yu. Neklasova,  and Vladimir N. Anisimov
3723-3729
Abstract  |  PDF  |  Full Text  |  How to cite  |  Press Release  |  Order a Reprint

Evaluation of cellular alterations and inflammatory profile of mesothelial cells and/or neoplastic cells exposed to talc used for pleurodesis

Evaluation of cellular alterations and inflammatory profile of mesothelial cells and/or neoplastic cells exposed to talc used for pleurodesis

https://doi.org/10.18632/oncotarget.27750

Milena Marques Pagliarelli Acencio, Bruna Rocha Silva, Lisete Ribeiro Teixeira, Vanessa Adélia Alvarenga, Carlos Sérgio Rocha Silva, Aline Graças Pereira da Silva, Vera Luiza Capelozzi,  and Evaldo Marchi
3730-3736
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Efavirenz induces DNA damage response pathway in lung cancer

Efavirenz induces DNA damage response pathway in lung cancer

https://doi.org/10.18632/oncotarget.27725

Rahaba Marima, Rodney Hull, Zodwa Dlamini,  and Clement Penny
3737-3748
Abstract  |  PDF  |  Full Text  |  How to cite  |  Podcast  |  Order a Reprint

Corrections

Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor

Correction: Preclinical evaluation of biomarkers associated with antitumor activity of MELK inhibitor

https://doi.org/10.18632/oncotarget.27755

Suyoun Chung, Kyoko Kijima, Aiko Kudo, Yoshiko Fujisawa, Yosuke Harada, Akiko Taira, Naofumi Takamatsu, Takashi Miyamoto, Yo Matsuo,  and Yusuke Nakamura
3749-3750
Correction  |  PDF  |  How to cite


Copyright © 2020 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC